Business Wire1mon
$52.46 Bn Blood Glucose Monitoring Devices Focused Market Insights 2024-2029: Next-generation Blood Glucose Monitoring Systems, Flash Glucose Monitoring, Government Initiatives ...
many investigational and small companies are coming into existence with blood glucose monitoring devices. F. Hoffmann-La Roche, Abbott, Dexcom, Medtronic, Ascensia Diabetes Care Holdings AG ...
Khaleej Times20y
Glucose meter
DUBAI — Bayer Health Care’s Diabetes Care Division is launching Ascensia Contour blood glucose meter, a new self-testing system to help provide comprehensive diabetes control. The new meter is ...
Senseonics Stock Surges 42% After Hours on Preliminary Revenue Report
Strategically, Senseonics called off a Special Meeting of Stockholders scheduled to review a reverse stock split. Management ...
drugdeliverybusiness12d
Senseonics to consider reverse stock split, reports strong Eversense 365 interest
Senseonics (NYSE:SENS) announced preliminary financial results for 2024 as it considers a reverse stock split.
Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting
GERMANTOWN, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- (NYSE American: SENS), a medical technology company focused on the ...
Stockhouse1mon
Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch
implantable continuous glucose monitoring (CGM) systems for people with diabetes, today provided commercial updates related to the Eversense® 365 launch. Launched Eversense 365 in October ...
Nasdaq13d
Senseonics Holdings, Inc. Reports Strong Q4 2024 Performance and Launch of Eversense 365 Continuous Glucose Monitoring System
For important safety information, see Ascensia Diabetes Care is a global ... We are home to the world-renowned CONTOUR portfolio of blood glucose monitoring systems and the exclusive global ...